Lack of morphine and enkephalin tolerance in 129/SvEv mice: Evidence for a NMDA receptor defect

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 455-459

  Kolesnikov, Yuri ^a   Jain, Subash ^a   Wilson, Roger ^a   Pasternak, Gavril W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Population Medicine and Diagnostic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ARGININE; ENKEPHALIN; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE BENZOYLHYDRAZONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; ARGININE; DRUG TOLERANCE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MICE; MICE, INBRED STRAINS; MORPHINE; NITRIC OXIDE; NITROPRUSSIDE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA;

EID: 0031931822     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Babey AM, Kolesnikov Y, Cheng J, Inturrisi CE, Trifilletti RR and Pasternak GW (1994) Nitric oxide and opioid tolerance. Neuropharmacology 33:1463-1470.
2. Baron A, Shuster L, Elefterhiou BE and Bailey DW (1975) Opiate receptors in mice: Genetic differences. Life Sci 17:633-640.
3. Ben-Eliyahu S, Marek P, Vaccarino AL, Mogil JS, Sternberg WF and Liebeskind JC (1992) The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 575: 304-308.
4. Bhargava HN (1994) Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol. Rev. 46:293-324.
5. Bhargava HN and Matwyshyn GA (1993) Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology 47:344-350.
6. 5 enkephalin and morphine in the mouse. Neuropeptides 30:219-223.
7. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:174-179.
8. Dunbar S and Yaksh TL (1996a) Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 84: 1177-1188.
9. Dunbar S and Yaksh TL (1996b) Effect of spinal infusion of L-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Neurosci Lett 207:33-36.
10. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56:69-75.
11. Elliott KJ, Brodsky M, Hynansky A, Foley KM and Inturrisi CE (1995) Dextromethorphan shows efficacy in experimental pain (nociception) and opioid tolerance. Neurology 45:S66-S68.
12. Elmer GI, Pieper JO, Goldberg SR and George FR (1995) Opioid operant self-administration, analgesia, stimulation and respiratory depression in μ-deficient mice. Psychopharmacology (Berl) 117:23-31.
13. Gutstein HB and Trujillo KA (1993) MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res 626:332-334.
14. Haley TJ and McCormick WG (1957) Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12:12-15.
15. Kolesnikov YA, Pan Y-X, Babey A-M, Jain S, Wilson R and Pasternak GW (1997) Functionally differentiating two nNOS isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci USA 94:8220-8225.
16. G-Nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221:339-340.
17. 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. Life Sci 53:1489-1494.
18. Kolesnikov YA, Maccechini M-L and Pasternak GW (1994) 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci 55:1393-1398.
19. Kolesnikov YA, Pick CG, Ciszewska G and Pasternak GW (1993b) Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 90:5162-5166.
20. London ED, Vaupel DB and Kimes AS (1994) Inhibitors of nitric oxide synthase as potential treatments for opioid withdrawal. Regal Pept 54:165-166.
21. Luke MC, Hahn EF, Price M and Pasternak GW (1988) Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci 43:1249-1256.
22. Lutfy K, Shen K-Z, Kwon I-S, Cai SX, Woodward RM, Keana JFW and Weber E (1995) Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/ glycine site antagonist. Eur J Pharmacol 273:187-189.
23. Manning BH, Mao JR, Frenk H, Price DD and Mayer DJ (1996) Continuous co-administration of dextromethorphan or MK-801 with morphine: Attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 67:79-88.
24. Pan Y-X, Cheng J, Xu J, Rossi GC, Jacobson E, Ryan-Moro J, Brooks AI, Dean GE, Standifer KM and Pasternak GW (1995) Cloning and functional characterization through antisense mapping of a kappa-3-related opioid receptor. Mol Pharmacol 47:1180-1188.
25. Pasternak GW, Kolesnikov YA and Babey AM (1995) Perspectives on the N-methyl-D-aspartate nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 13:309-313.
26. Pick CG, Nejat R and Pasternak GW (1993) Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J Pharmacol Exp Ther 2265:166-171.
27. 2) revealed by morphine-induced antinociception vs endothelin-1 in recombinant inbred CXBK mice. Life Sci 54:57-62.
28. Reisine T and Pasternak GW (1996) Opioid analgesics and antagonists. In Goodman and Gilman's: The Pharmacological Basis of Therapeutics, ed. by J. G. Hardman and L. E. Limbird, pp. 521-556, McGraw-Hill, New York.
29. Reith MEA, Sershen H, Vadasz C and Lajtha A (1981) Strain differences in opiate receptors in mouse brain. Eur J Pharmacol 74:377-380.
30. Rossi GC, Pan Y-X, Brown GP and Pasternak GW (1995) Antisense mapping the MOR-1 opioid receptor: Evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett 369:192-196.
31. Rossi GC, Brown GP, Leventhal L, Yang K and Pasternak GW (1996) Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia. Neurosci Lett 216:1-4.
32. Standifer KM, Chien C-C, Wahlestedt C, Brown GP and Pasternak GW (1994) Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12:805-810.
33. Tiseo P and Inturrisi CE (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate antagonist LY274614. J Pharmacol Exp Ther 264:1090-1096.
34. Trujillo KA and Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
35. Trujillo KA and Akil H (1994) Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res 633:178-188.
36. Umans JG and Inturrisi CE (1981) Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice. J Pharmacol Exp Ther 218:409-415.
37. Vaught JL, Mathiasen JHR and Raffa RB (1988) Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. J Pharmacol Exp Ther 245:12-16.
38. Vaupel DB, Kimes AS and London ED (1995) Nitric oxide synthase inhibitors -Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology 13:315-322.